These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15347821)

  • 1. Indicators of malignancy of canine adrenocortical tumors: histopathology and proliferation index.
    Labelle P; Kyles AE; Farver TB; De Cock HE
    Vet Pathol; 2004 Sep; 41(5):490-7. PubMed ID: 15347821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
    Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
    Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
    Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
    Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.
    Takehara K; Sakai H; Shono T; Irie J; Kanetake H
    Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas.
    Iino K; Sasano H; Yabuki N; Oki Y; Kikuchi A; Yoshimi T; Nagura H
    Mod Pathol; 1997 Sep; 10(9):901-7. PubMed ID: 9310953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.
    Schmitt A; Saremaslani P; Schmid S; Rousson V; Montani M; Schmid DM; Heitz PU; Komminoth P; Perren A
    Histopathology; 2006 Sep; 49(3):298-307. PubMed ID: 16918977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cushing's syndrome due to a large adrenocortical adenoma with histological features simulating ACTH-independent macronodular adrenocortical hyperplasia.
    Karasawa R; Hotta M; Aiba M; Takano K
    Pathol Int; 2004 Apr; 54(4):273-8. PubMed ID: 15028030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis.
    Stojadinovic A; Brennan MF; Hoos A; Omeroglu A; Leung DH; Dudas ME; Nissan A; Cordon-Cardo C; Ghossein RA
    Mod Pathol; 2003 Aug; 16(8):742-51. PubMed ID: 12920217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adrenocortical tumors: mitotic index and nuclear size as criteria for differential diagnosis and prognosis].
    Poliakova GA; Kazantseva IA; Kalinin AP; Perov AI; Bokova EV
    Arkh Patol; 1999; 61(3):30-4. PubMed ID: 10476345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
    Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
    Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine hyperadrenocorticism due to adrenocortical neoplasia. Pretreatment evaluation of 41 dogs.
    Reusch CE; Feldman EC
    J Vet Intern Med; 1991; 5(1):3-10. PubMed ID: 1850483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative aspects of Cushing's syndrome in dogs and cats.
    Feldman EC; Nelson RW
    Endocrinol Metab Clin North Am; 1994 Sep; 23(3):671-91. PubMed ID: 7805662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?
    Sturgeon C; Shen WT; Clark OH; Duh QY; Kebebew E
    J Am Coll Surg; 2006 Mar; 202(3):423-30. PubMed ID: 16500246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors.
    Terzolo M; Boccuzzi A; Bovio S; Cappia S; De Giuli P; Alì A; Paccotti P; Porpiglia F; Fontana D; Angeli A
    Urology; 2001 Jan; 57(1):176-82. PubMed ID: 11164177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
    de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
    Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic and immunohistochemical classification of 41 bovine adrenal gland neoplasms.
    Grossi AB; Leifsson PS; Jensen HE; Vainer B; Iburg T
    Vet Pathol; 2013 May; 50(3):534-42. PubMed ID: 23242804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical analysis of 103 cases of adrenal incidentaloma].
    Tao H; Lu ZL; Li HZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):172-5. PubMed ID: 12905714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing's syndrome associated with bilateral adrenal adenomas.
    Mimou N; Sakato S; Nakabayashi H; Saito Z; Takeda R; Matsubara F
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):245-54. PubMed ID: 3969816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with adrenocortical neoplasms in childhood.
    Neblett WW; Frexes-Steed M; Scott HW
    Am Surg; 1987 Mar; 53(3):117-25. PubMed ID: 3826904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior.
    Papotti M; Volante M; Duregon E; Delsedime L; Terzolo M; Berruti A; Rosai J
    Am J Surg Pathol; 2010 Jul; 34(7):973-83. PubMed ID: 20534995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.